Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-01-16

Clinical Trial Update: Comparative Study Between Vaginal Progesterone Alone or Combined With Aspirin in Prevention of Recurrent Preterm Birth [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing vaginal progesterone alone versus combined with aspirin for prevention of recurrent preterm birth has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)
  • Progesterone (vaginal) (progesterone)

Snippet

Sponsor: Menoufia University | Conditions: Preterm Birth | Phase 4 | Status: COMPLETED